30 April 2024
Amigo Holdings PLC
("Amigo" or the "Company")
Result of General Meeting
Amigo Holdings PLC (LSE: AMGO) announces that at the General Meeting ("GM") held earlier today at the Bournemouth Highcliff Marriott Hotel, 105 St Michael's Road, Bournemouth BH2 5DU, the Resolution set out in the Notice of General Meeting published on 9 April 2024 ("Notice") was duly passed. In accordance with Listing Rule 9.6.2R, a copy of the Resolution passed will shortly be submitted to the National Storage Mechanism.
A summary of the result in respect of the Resolution is set out below. The Resolution was passed as a special resolution.
Resolution |
Number of votes for |
% |
Number of votes against |
% |
Number of votes withheld |
Authority for disapplication of pre-emption rights |
23,071,580 |
97.94% |
484,257 |
2.06% |
1,059,386 |
Notes:
1. Votes "for" include proxy appointments which gave discretion to the Chair of the AGM. A "vote withheld" is not a vote under English law and therefore the percentage of voting shares is the percentage of shares voted and excludes shares on which votes were withheld.
2. As at 13.30 p.m. on Friday, 26 April 2024, being the time at which a person had to be registered in the Company's register of members in order to vote at the AGM, the number of ordinary shares of the Company in issue was 499,100,160.
As previously announced on 9 April 2024, the issue of the Second Placing Shares was conditional on: (i) the approval of shareholders to dis-apply their Companies Act 2006 pre-emption rights over such issue at the General Meeting held earlier today; (ii) on regulatory approval for an internal reorganisation, which insulates the Capital Raise monies from the Scheme processes; and (iii) the Second Placing Shares being listed on the premium segment of the Official List and to being admitted to trading on the main market for listed securities of the London Stock Exchange.
The Company confirms that it has also received any necessary regulatory approvals for the internal reorganisation referred to above. Accordingly, application has been made for the 71,252,800 Second Placing Shares to be listed on the premium segment of the Official List and to be admitted to trading on the main market for listed securities of the London Stock Exchange, which is expected to occur on or about 8 May 2024 ("Admission"). The Second Placing Shares will rank pari passu in all respects with the Existing Issued Ordinary Shares including voting, entitlement to income and entitlement on a return of capital.
Unless the context otherwise requires, capitalised terms in this announcement shall have the same meaning ascribed to them in the Notice.
Contacts:
Amigo Holdings PLC |
investors@amigo.me |
Nick Beal |
Company Secretary
|
|
|
Media Enquiries |
Amigoloans@lansons.com |
Ed Hooper |
07783 387713
|
|
|
Corporate Broker Lucy Williams / Duncan Vasey |
Peterhouse Capital Limited 020 7469 0936
|
|
|
Sponsor |
Beaumont Cornish 0207 628 3396 |
|
|
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Sponsor as defined in the FCA Listing Rules and is authorised and regulated by the FCA. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.
This announcement is not intended to, and does not, constitute or form part of any offer, invitation, or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell, or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.